Treatment of Chronic Liver Fibrosis: Adipose and Bone Marrow Mesenchymal Stem Cells
International Journal of Molecular Sciences · 13.06.2026 · 27 (12) · 5340
DOI: 10.3390/ijms27125340 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.06.2026. Verfasst von Murat Shagidulin und 23 weiteren Autor:innen. Beteiligte Einrichtung: Shumakov National Medical Research Center of Transplantology and Artificial Organs, Moscow 123182, Russia. Hauptthemen laut MEDLINE: Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells, Liver Cirrhosis, Bone Marrow Cells. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Liver fibrosis is a severe but common disease without an easy-to-access option for efficient treatment. Mesenchymal stem cells (MSCs) of different origins have been tested for antifibrotic effects in vitro, in vivo, and in clinical studies over the two last decades, although the comparative efficiency of different subtypes remains not fully understood, especially for long-term survival. In this study, we aimed to compare the long-time persistence of favorable effects in male Wistar rats with liver fibrosis treated using MSCs derived from white adipose tissue (AdMSCs) and bone marrow (BMSCs). Liver fibrosis was induced by carbon tetrachloride. We studied the survival rate; oxidative index, assessed via laser Doppler flowmetry; hepatic markers in blood plasma—albumin, alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase; the ratio of liver to body mass; histological parameters—the number of adipocytes, lymphocytes, siderophages, and Ki67+ cells; and the relative areas of connective tissue proper and reticular fibers. Extra mortality was only typical for fibrotic animals subjected to the sham treatment in the first two weeks. Up to Day 270 of this study, both MSC-treated groups showed barely any differences from animals undergoing the sham treatment in terms of the oxidative index and blood markers, although AdMSC-treated rats presented a more favorable histological pattern than BMSC-treated ones, considering the relative area of reticular fibers and the Ki67 cell count. This study suggests that AdMSC treatments may be more appropriate than BMSC treatments in animal liver fibrosis models, with the results showing better potential for liver tissue regeneration 9 months after treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shumakov National Medical Research Center of Transplantology and Artificial Organs, Moscow 123182, Russia.
- Department of Transplantology and Artificial Organs, Sechenov First Moscow State Medical University, Moscow 119991, Russia.
- Department of Human Anatomy and Histology, Sechenov First Moscow State Medical University, Moscow 119991, Russia.
- Soft Matter and Physics of Fluids Center, Bauman Moscow State Technical University, Moscow 105005, Russia.
ORCID-Profile: Murat Shagidulin, Artem Venediktov, Alexei Grigoriev, Mila Ibragimova, Aglaya Arzhanova, Pavel Fadeev, Valekh Ashyrov, Viktoria Gartseva, Anastasia Kostysheva, Ivan Lychagin, Alla Nikolskaya, Sergei Pershikov, Egor Kuzmin, Ksenia Pokidova, Yulia Basok, Nina Onishchenko, Gennadii Piavchenko, Sergei Gautier
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Shagidulin, M., Venediktov, A., Grigoriev, A., Ibragimova, M., Aktemirov, A., Arzhanova, A., Fadeev, P., Ashyrov, V., Gartseva, V., Kostysheva, A., Lychagin, I., Ponomareva, A., Salomatina, L., Vaniukova, A., Nikolskaya, A., Pershikov, S., Kuzmin, E., Pokidova, K., Zharov, N., …, & Gautier, S. (2026). Treatment of Chronic Liver Fibrosis: Adipose and Bone Marrow Mesenchymal Stem Cells. International Journal of Molecular Sciences, 27(12), 5340. https://doi.org/10.3390/ijms27125340
Vancouver
Shagidulin M, Venediktov A, Grigoriev A, Ibragimova M, Aktemirov A, Arzhanova A, et al. Treatment of Chronic Liver Fibrosis: Adipose and Bone Marrow Mesenchymal Stem Cells. International Journal of Molecular Sciences. 2026;27(12):5340. doi:10.3390/ijms27125340
BibTeX
@article{Shagidulin2026,
author = {Shagidulin, Murat and Venediktov, Artem and Grigoriev, Alexei and Ibragimova, Mila and Aktemirov, Artur and Arzhanova, Aglaya and Fadeev, Pavel and Ashyrov, Valekh and Gartseva, Viktoria and Kostysheva, Anastasia and Lychagin, Ivan and Ponomareva, Anna and Salomatina, Lidia and Vaniukova, Alina and Nikolskaya, Alla and Pershikov, Sergei and Kuzmin, Egor and Pokidova, Ksenia and Zharov, Nikolai and Kartashkina, Natalia and Basok, Yulia and Onishchenko, Nina and Piavchenko, Gennadii and Gautier, Sergei},
title = {Treatment of Chronic Liver Fibrosis: Adipose and Bone Marrow Mesenchymal Stem Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {12},
pages = {5340},
doi = {10.3390/ijms27125340}
}
EUVIMED